Correlation Between Exicure and Protagenic Therapeutics

Can any of the company-specific risk be diversified away by investing in both Exicure and Protagenic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exicure and Protagenic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Exicure and Protagenic Therapeutics, you can compare the effects of market volatilities on Exicure and Protagenic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exicure with a short position of Protagenic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exicure and Protagenic Therapeutics.

Diversification Opportunities for Exicure and Protagenic Therapeutics

0.38

Correlation Coefficient

Exicure  Protagenic Therapeutics

Weak diversification

The 3 months correlation between Exicure and Protagenic is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Exicure and Protagenic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagenic Therapeutics and Exicure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exicure are associated (or correlated) with Protagenic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagenic Therapeutics has no effect on the direction of Exicure i.e., Exicure and Protagenic Therapeutics go up and down completely randomly.

Pair Corralation between Exicure and Protagenic Therapeutics

Given the investment horizon of 90 days Exicure is expected to generate 1.31 times more return on investment than Protagenic Therapeutics. However, Exicure is 1.31 times more volatile than Protagenic Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Protagenic Therapeutics is currently generating about -0.11 per unit of risk. If you would invest  1,615  in Exicure on December 30, 2024 and sell it today you would lose (216.00) from holding Exicure or give up 13.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Exicure  vs.  Protagenic Therapeutics

Exicure

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Exicure are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Exicure reported solid returns over the last few months and may actually be approaching a breakup point.

Protagenic Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Protagenic Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Exicure and Protagenic Therapeutics

The main advantage of trading using opposite Exicure and Protagenic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exicure position performs unexpectedly, Protagenic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagenic Therapeutics will offset losses from the drop in Protagenic Therapeutics' long position.

The idea behind Exicure and Protagenic Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.